Table 4 shows the prevalence of diagnostic inertia according to comorbidities. A higher risk for inertia was observed in women without heart failure (20.2%), without atrial fibrillation (20.1%), without diabetes mellitus (21.3%), without arterial hypertension (21.4%), and without retinopathies (20.1%) (p < 0.025). By treatment, diagnostic inertia was more frequent in women who were not receiving antiplatelet agents, insulin, oral antidiabetic drugs, antithrombotics, or lipid-lowering drugs (p < 0.001). The gene discussed is INS; the disease is heart failure.